Elite Pharmaceuticals, Inc. Conversion of Stock, Shares Converted
Elite Pharmaceuticals, Inc. (ELTP) reported Conversion of Stock, Shares Converted of 79.01 million shares for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2020-08-14
- Elite Pharmaceuticals, Inc. conversion of stock, shares converted for the quarter ending 2020-06-30 was 79.01M shares.
- Elite Pharmaceuticals, Inc. conversion of stock, shares converted for fiscal 2015 was 4.24 shares, a 99.87% decline from fiscal 2014.
- Elite Pharmaceuticals, Inc. conversion of stock, shares converted for fiscal 2014 was 3.17K shares, a 28.28% increase from fiscal 2013.
- Elite Pharmaceuticals, Inc. conversion of stock, shares converted for fiscal 2013 was 2.48K shares, a 70.80% decline from fiscal 2012.
- Elite Pharmaceuticals, Inc. conversion of stock, shares converted for fiscal 2012 was 8.48K shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|
| 2020-06-30 | 79.01M shares 10-Q · filed 2020-08-14 | |
| 2015-03-31 | 4.24 shares 10-K · filed 2015-06-15 | |
| 2014-03-31 | 3.17K shares 10-K · filed 2015-06-15 | |
| 2013-03-31 | 2.48K shares 10-K · filed 2014-06-30 | |
| 2012-03-31 | 8.48K shares 10-K · filed 2013-06-21 |